These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9236426)

  • 21. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
    White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ
    Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
    JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
    J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary mechanical recanalization of occluded coronary arteries without prior thrombolytic therapy in patients with acute myocardial infarction. A single-center study reporting acute results and complications.
    Emmerich K; Ulbricht LJ; Probst H; Krakau I; Hoffmeister T; Lürken E; Thale J; Gülker H
    Z Kardiol; 1995; 84 Suppl 2():5-23. PubMed ID: 7571783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Hochman JS; Buller CE; Sleeper LA; Boland J; Dzavik V; Sanborn TA; Godfrey E; White HD; Lim J; LeJemtel T
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1063-70. PubMed ID: 10985706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival?
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2002 May; 143(5):768-76. PubMed ID: 12040336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary angioplasty for cardiogenic shock complicating acute myocardial infarction.
    Calton R; Jaison TM; David T
    Indian Heart J; 1999; 51(1):47-54. PubMed ID: 10327779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction.
    O'Neill WW; Weintraub R; Grines CL; Meany TB; Brodie BR; Friedman HZ; Ramos RG; Gangadharan V; Levin RN; Choksi N
    Circulation; 1992 Dec; 86(6):1710-7. PubMed ID: 1451242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS;
    JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiogenic shock in acute myocardial infarction. Improving survival rates by primary coronary angioplasty.
    Emmerich K; Ulbricht LJ; Probst H; Krakau I; Hoffmeister T; Thale J; Gülker H
    Z Kardiol; 1995; 84 Suppl 2():25-42. PubMed ID: 7571781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Dauerman HL; Goldberg RJ; White K; Gore JM; Sadiq I; Gurfinkel E; Budaj A; Lopez de Sa E; Lopez-Sendon J;
    Am J Cardiol; 2002 Oct; 90(8):838-42. PubMed ID: 12372570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators.
    Hochman JS; Boland J; Sleeper LA; Porway M; Brinker J; Col J; Jacobs A; Slater J; Miller D; Wasserman H
    Circulation; 1995 Feb; 91(3):873-81. PubMed ID: 7828316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries.
    Holmes DR; Califf RM; Topol EJ
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):10S-17S. PubMed ID: 7775708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry.
    Dzavik V; Sleeper LA; Cocke TP; Moscucci M; Saucedo J; Hosat S; Jiang X; Slater J; LeJemtel T; Hochman JS;
    Eur Heart J; 2003 May; 24(9):828-37. PubMed ID: 12727150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Kleiman NS; White HD; Ohman EM; Ross AM; Woodlief LH; Califf RM; Holmes DR; Bates E; Pfisterer M; Vahanian A
    Circulation; 1994 Dec; 90(6):2658-65. PubMed ID: 7994805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.